# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
– Two presentations highlighting data on DAXXIFY® for the treatment of cervical dystonia, including a new analysis from ASPEN t...
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...
U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdin...
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
Revance Therapeutics, Inc. (NASDAQ:RVNC) ("Revance" or the "Company") today announced the pricing of an underwr...
Goldman Sachs analyst Chris Shibutani maintains Revance Therapeutics (NASDAQ:RVNC) with a Neutral and raises the price targe...
HC Wainwright & Co. analyst Douglas Tsao reiterates Revance Therapeutics (NASDAQ:RVNC) with a Buy and maintains $12 pric...